Indo Us Biotech Limited — Others, 16-12-2024: Shareholders meeting

Indo-US Bio-Tech Limited has announced the results of a postal ballot, confirming the increase in its authorized share capital from ₹21 crore to ₹32 crore and the corresponding amendment to its Memorandum of Association. The remote e-voting process showed overwhelming support, with over 99.99% of votes in favor from participating shareholders. This decision is anticipated to empower the company to raise funds and support future growth initiatives. Investors may view this as a positive outlook, reflecting management's proactive approach to capitalizing on market opportunities.